Advertisement
Decreasing VAP Risk in the ED

Decreasing VAP Risk in the ED

Ventilator-associated pneumonia (VAP) results in increased morbidity, mortality, and healthcare costs. Unfortunately, clinical evidence of VAP occurs 48 hours or more after intubation, meaning it manifests days after the disease process has begun in the ED. Efforts are needed to implement interventions to reduce VAP risk in the ED setting and to make prevention a higher priority. Prevention Strategies For Decreasing VAP There is compelling evidence that pre-hospital and ED intubation, as well as ED length of stay, are risk factors for the development of VAP, particularly in the trauma population. In the March 2012 Journal of Emergency Medicine, my colleagues and I had an article published that identified several strategies to help EDs reduce the risk of VAP: Backrest Elevation: Continuous backrest elevation of 30° to 45° is recommended for all intubated ED patients without contraindications. A collaborative effort is required to ensure compliance. Oral Care: Oral care strategies should be implemented in the ED as early as possible. These include a chlorhexidine application to the oral cavity immediately after intubation and every 12 hours thereafter. Endotracheal Tubes (ETTs): Reducing the use of ETTs with non-invasive ventilation strategies may reduce VAP incidence. Guidelines suggest that intubation should be avoided, if possible. Cuff Pressure Management: The movement of secretions from the oral cavity into the subglottic space and eventually into the lungs increases the risk of VAP. An effective ETT cuff seal may reduce secretion movement. ETT cuff pressure monitoring should be performed as soon as possible after intubation, and pressures should be maintained between 20 cm H2O and 30 cm H2O in the ED and continued at regular...
[ HIDE/SHOW ]